Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1

Conditions

Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Paclitaxel 77 pembrolizumab 65 Carboplatin 57 Bevacizumab 57 Specimen Handling 49 Magnetic Resonance Spectroscopy 40 Cisplatin 35 olaparib 31 Gemcitabine 27 liposomal doxorubicin 25 Biopsy 22 Taxes 19 Cyclophosphamide 18 Topotecan 17 Nivolumab 17 Doxorubicin 16 Immunoglobulin G 15 niraparib 14 Letrozole 14 Disulfides 14 lenvatinib 13 fludarabine 13 Surveys and Questionnaires 12 Drug Therapy 12 Radiotherapy 11 Platinum 11 atezolizumab 10 abemaciclib 10 durvalumab 9 Fulvestrant 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

adacel × Gynecologic × 90 days × Clear all

NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡